Share price: 112.80p

INTERIM RESULTS

11th September 2007

A solid platform for a strong full year

Cello Group plc (“Cello”, AIM: CLL. “The Group”), the market research and consulting group, today announces its interim results for the 6 month period to 30 June 2007.

Financial Highlights

• Turnover up 44% to £45.8m (2006: £31.7m)

• Operating income up 38% to £24.4m (2006: £17.7m)

• Headline profit before tax up 19% to £3.1m (2006: £2.6m)

• Like-for-like operating income growth of 20%

• Like-for-like operating profit growth of 6%

• Basic headline earnings per share up 15% to 6.42p (2006: 5.60p)

• Interim dividend up 12.5% to 0.45p (2006: 0.4p)

Operational Highlights

• Continued organic revenue growth fuelled by large contract wins

• Invested heavily to increase organic professional headcount by 15%

• Three acquisitions completed

– Rosenblatt/Digital People, a qualitative market research agency

– MSI, a leading healthcare research consultancy

– mruk research, a public sector market research specialist agency

Kevin Steeds, Chairman, commented:

 

“During the last six months we have continued our focused strategy – to make highly selective acquisitions and invest heavily in people to support our growth.

 

“As we approach the end of our third full year as a public company, we have much to be proud of. Cello is now firmly established as a leading research and consulting business, with an outstanding group of 650 professionals, a roster of blue-chip global clients, and prudent financing. We now move forward from a position of strength.”

 

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150